How Verastem hopes to get from founding to NDA in 6 years
July 29, 2013 at 13:48 PM EDT
Sitting in a conference room in Verastem Inc.'s (Nasdaq: VSTM) Cambridge headquarters, President and CEO Robert Forrester describes his three-year-old biotech this way: “We’re a little company that knows a lot about a little...